Wolfgang Knauf

Two years rituximab maintenance vs. observation after first-line treatment with bendamustine plus rituximab (B-R) in patients with mantle cell lymphoma: First results of a prospective, randomized, multicenter phase II study (a subgroup study of the StiL NHL7-2008 MAINTAIN trial).

Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms

Mobile geriatrische Rehabilitation bei funktionell schwer beeinträchtigten Patienten

Supplementary Material for: Treatment of Non-Transplant Patients with Multiple Myeloma: Routine Treatment by Office-Based Haematologists in Germany - Data from the Prospective Tumour Registry Lymphatic Neoplasms (TLN)

Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO study

Chronic Lymphocytic Leukemia Research

Lymphoma Diagnosis and Treatment

Multiple Myeloma Research and Treatments

Hematopoietic Stem Cell Transplantation

Protein Degradation and Inhibitors